Statewide

Generosity from anonymous donors will support research and aid in the development of new treatments for hard-to-treat or incurable diseases, to the benefit of patients everywhere.

Generosity from anonymous donors will support research and aid in the development of new treatments for hard-to-treat or incurable diseases, to the benefit of patients everywhere.

UVA Licensing & Ventures Group helps UVA researchers secure patents for their inventions and launch start-up companies.

UVA Licensing & Ventures Group helps UVA researchers secure patents for their inventions and launch start-up companies.

A new way of thinking about Alzheimer's disease has yielded a UVA research discovery that could be the key to stopping the cognitive decline seen in Alzheimer's and other neurodegenerative diseases.

Esser will work with scientists to accelerate the development of new medicines and treatments for illnesses like cancer and Alzheimer's.

One of Esser's responsibilities will be to foster an "ecosystem of innovation" that will attract biotechnology and pharmaceutical companies to Central Virginia and the greater Commonwealth.

The Commonwealth BioAccelerator officially opened its doors, transforming 6,500 square feet of cutting-edge lab space into a launchpad for Virginia's most promising biotech ventures.

The Commonwealth BioAccelerator officially opened its doors, transforming 6,500 square feet of cutting-edge lab space into a launchpad for Virginia's most promising biotech ventures.

CvilleBioHub, a regional, industry-led organization, received a $4.3 million GO Virginia award and is partnering with UVA to establish the region's first laboratory accelerator at North Fork.

CvilleBioHub, a regional, industry-led organization, received a $4.3 million GO Virginia award and is partnering with UVA to establish the region's first laboratory accelerator at North Fork.

A statewide biopharma boom is fueled by talent emerging from Virginia's universities, which provide a steady pipeline of specialized labor.